Insilico Medicine

This biotechnology company, established in 2014, is headquartered in Hong Kong and New York. It leverages genomics, big data analysis, and deep learning for in silico drug discovery. The company is also engaged in artificial intelligence for drug discovery and aging research, contributing significantly to the field of biotechnology.